FDA approved Pfizer-BioNTech’s XFG-adapted COMIRNATY formula for adults 65 and older and high-risk people aged 5 to 64 years.
|Articles|June 9, 2021
COVID-19 Updates: US Vaccinations and Global Cases and Deaths as of June 9, 2021
Author(s)Sydney Jennings
Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 vaccinations, cases, and deaths in the US and on cases and deaths worldwide.
Advertisement
How many people in the US have been vaccinated against COVID-19?
According to the US
• 51.8% of total US population has received at least 1 dose
• 42.5% of total US population is fully vaccinated
• 42.5% of total US population is fully vaccinated
The 5 states with the highest percentage of population fully vaccinated are:
1. Vermont: 59.5%
2. Maine: 56.8%
3. Massachusetts: 56.8%
4. Connecticut: 55.7%
5. Rhode Island: 53.8%
2. Maine: 56.8%
3. Massachusetts: 56.8%
4. Connecticut: 55.7%
5. Rhode Island: 53.8%
How many cases of COVID-19 have been confirmed in the US?
According to the
• 33 402 758 confirmed cases
• 598 638 deaths
• 598 638 deaths
The 5 states with the highest total confirmed cases are:
1. California: 3 798 313
2. Texas: 2 968 690
3. Florida: 2 332 867
4. New York: 2 107 289
5. Illinois: 1 386 180
2. Texas: 2 968 690
3. Florida: 2 332 867
4. New York: 2 107 289
5. Illinois: 1 386 180
Deaths: California has the most deaths due to COVID-19 with 63 627 reported fatalities, followed by New York with 53 492, and Texas with 51 778.
How many cases of COVID-19 have been confirmed globally?
Globally, there have been 174 140 310 confirmed cases, 3 750 518 deaths, and 2 206 849 579 vaccine doses administered.
Advertisement
Related to this article
A Vaccine Integrity Project review found influenza, COVID-19, and RSV immunizations continue to protect against severe illness, hospitalization, and death.
Pre-existing antibodies to common microbes predicted COVID-19 vaccine response strength in healthy and immunosuppressed adults.
FDA approved bictegravir/lenacapavir for adults with suppressed HIV-1 and no known or suspected component resistance.
FDA expands dolutegravir dispersible tablets to children with HIV-1 weighing at least 2 kg, including eligible term newborns.
The organizations challenge a presidential executive order narrowing routine childhood vaccine recommendations and urging vaccines to be given separately.
FDA updates sotatercept-csrk label with HYPERION data, showing earlier use cuts PAH clinical worsening risk 76% alongside background therapy.
A US laboratory study found that 29.5% of patients with Lyme antibodies were seropositive for at least 1 other tick-borne pathogen.
Advertisement
Advertisement
Trending on Patient Care Online
1
FDA Approves Sotatercept-csrk Label Update for Newly Diagnosed PAH
2
Endocrine Society Obesity Statement Calls for Goals Beyond Weight Loss
3
Lumateperone Reduces Acute Mania Symptoms in Phase 3 Bipolar I Trial
4
Clinical Inertia and Poor Measurement Technique Undermine BP Control
5